Anteris Technologies Ltd (AVR) is a dedicated structural heart company focused on advancing medical device innovation. With a robust team of multidisciplinary professionals, Anteris is committed to developing and commercialising cutting-edge solutions for patients with structural heart disease. The company distinguishes itself through a rigorous scientific approach, aiming to revolutionise the heart valve replacement market. By prioritising superior clinical outcomes and innovative design, Anteris strives to set new standards in the field, offering hope and improved quality of life to patients worldwide.